Nigeria Raises Alarm Over Drug-Resistant Infections, Calls for Stronger Monitoring and Responsible Antibiotic Use

By Simpson Global Media News Desk

Nigeria’s Federal Government has acknowledged significant gaps in the country’s monitoring of antimicrobial resistance, warning that the available figures may not fully capture the scale of infections that are becoming increasingly difficult to treat with medicines.

The Coordinating Minister of Health and Social Welfare, Professor Muhammad Ali Pate, disclosed the surveillance challenges on Monday, October 12, during a joint ministerial briefing in Abuja ahead of the fifth Global High-Level Ministerial Conference on Antimicrobial Resistance (AMR), scheduled to take place in the Nigerian capital from December 6 to 8, 2026.

The government’s warning comes as officials from the health, agriculture, livestock and environment sectors seek a coordinated response to the growing threat posed by drug-resistant infections.

Pate said Nigeria had evidence of antimicrobial resistance in hospitals but lacked sufficient surveillance capacity to produce a complete and reliable national picture. He cautioned that the country’s estimates might differ from those of countries with more developed monitoring systems.

The minister also highlighted the use of antibiotics in livestock production, saying the sector uses more antibiotics than the human health sector. He called for more responsible use of these medicines to reduce the pressure that contributes to antimicrobial resistance.

The government is promoting a “One Health” approach that recognises the links between human health, animal health and the environment. Under this approach, preventing drug resistance requires action not only in hospitals and pharmacies but also on farms, throughout food production and in environmental management.

The December conference is expected to provide a platform for governments and international partners to discuss practical measures for translating global commitments into national action. <Cite refs={["turn585937search0","turn585937search1","turn585937search14","turn585937search16"]}/>

What Is Antimicrobial Resistance?

Antimicrobial resistance occurs when microorganisms, including bacteria, viruses, fungi and parasites, develop the ability to survive medicines that would ordinarily treat the infections they cause.

Antibiotic resistance is one part of the wider problem. It happens when bacteria become resistant to antibiotics, making particular infections more difficult to treat.

Antimicrobial resistance is a natural biological process, but inappropriate or excessive use of antimicrobial medicines can accelerate its development and spread.

When medicines become less effective, infections may persist for longer, treatment options can become limited, and patients may need additional tests, alternative medicines or more complex care.

In serious cases, resistant infections can contribute to severe illness or death. They can also increase the cost of treatment for patients, families and health systems.

The problem affects more than individual patients. Hospitals depend on effective antimicrobial medicines to treat infections and help protect patients undergoing surgery, cancer treatment, organ transplantation and other medical procedures.

If common infections become harder to treat, routine healthcare can become more complicated and expensive.

The World Health Organization identifies antimicrobial resistance as a major global public health threat. Addressing it requires appropriate prescribing, effective infection prevention, improved laboratory testing, access to quality medicines and stronger surveillance systems.

Nigeria’s latest warning focuses on the ability to understand where resistance is occurring, how frequently it is affecting patients and which interventions are most likely to reduce the problem. <Cite refs={["turn585937search1","turn585937search15","turn585937search16"]}/>

Nigeria Admits Gaps in National Surveillance

Surveillance is central to understanding the spread of drug-resistant infections.

It involves collecting, analysing and interpreting information about infections and the microorganisms responsible for them. Laboratory results can help clinicians identify the organisms causing an infection and determine which medicines are likely to work.

When hospitals and laboratories regularly share reliable information, public health authorities can identify patterns, monitor changes and develop better responses.

However, gaps in laboratory capacity, staffing, reporting systems and geographic coverage can leave important areas of the country underrepresented.

Pate acknowledged that Nigeria’s existing surveillance capacity was insufficient to provide a complete estimate of the national burden of antimicrobial resistance.

He said the available figures should be interpreted with caution because the quality and coverage of monitoring influence the estimates that can be produced.

The issue is important because a country cannot accurately assess the effectiveness of its response without understanding the problem it is trying to address.

If surveillance mainly captures infections in selected hospitals, for example, it may not adequately reflect the experience of people receiving care in smaller facilities or communities with limited laboratory access.

Likewise, if laboratories use inconsistent testing and reporting procedures, comparing results across locations can become difficult.

The government’s acknowledgement of these gaps does not mean that drug-resistant infections are absent from areas where data are limited. Rather, it means that the available evidence may not provide a complete picture.

Strengthening surveillance would help authorities identify priority infections, guide treatment policies, monitor trends and evaluate whether interventions are working.

It would also help researchers and policymakers estimate the financial and health consequences of antimicrobial resistance more reliably. <Cite refs={["turn585937search1","turn585937search11"]}/>

Estimates Point to a Significant Health Burden

Nigeria’s One Health Antimicrobial Resistance National Action Plan for 2024–2028 cites estimates suggesting that the country experienced a substantial burden of drug-resistant infections.

According to figures reported by Premium Times from the national action plan, an estimated 64,500 deaths in Nigeria in 2019 were attributable to antimicrobial resistance, while 263,400 deaths were associated with it.

These figures describe different measures. Deaths attributable to antimicrobial resistance estimate deaths that would not have occurred if the infections had remained susceptible to treatment, while deaths associated with resistance include deaths in which resistant infections were involved, even where other factors also contributed.

The estimates should not be interpreted as a current annual death count. They refer to 2019 and are subject to limitations in the underlying data.

Officials have warned that surveillance weaknesses may mean the figures do not capture the full burden.

A more complete national picture requires reliable data from a wider range of hospitals and laboratories, alongside consistent testing and reporting.

Improved surveillance can also help determine which infections are becoming resistant to particular medicines and whether resistance patterns differ by location or healthcare setting.

Such information is important for clinical decisions. A medicine that works against one type of infection may be ineffective against another, and resistance patterns can change over time.

For public health authorities, better estimates can support the allocation of resources to laboratories, infection prevention, staff training and treatment programmes.

Without reliable data, policymakers risk underestimating the problem or directing resources towards interventions that do not address the greatest needs. <Cite refs={["turn585937search1","turn585937search11"]}/>

Nigeria’s National AMR Survey

In December 2025, Nigeria launched its first nationally representative antimicrobial resistance survey to establish a baseline for understanding drug-resistant infections and strengthen routine surveillance.

The survey was designed to cover approximately 40 to 45 randomly selected health facilities and involve about 35,000 patients suspected of having bloodstream infections.

Its objectives include assessing the burden of antimicrobial resistance, examining associated illness and deaths, evaluating costs and strengthening laboratory and data systems.

A nationally representative survey can provide more structured evidence than information collected from a limited number of facilities, provided that its sampling and methods are implemented appropriately.

The planned inclusion of multiple facilities is particularly relevant because resistance patterns and laboratory capabilities may vary between institutions and locations.

A survey of this kind can also help identify practical obstacles, including the availability of diagnostic equipment, trained personnel and standardised procedures.

However, launching a survey is not the same as completing it or publishing its findings. The latest reports reviewed for this article do not establish a final set of results from the exercise.

The next important steps are the completion of data collection, analysis of findings and integration of lessons into routine surveillance and clinical practice.

Long-term monitoring will remain necessary because antimicrobial resistance is not static. The effectiveness of medicines can change as microorganisms evolve and as patterns of antimicrobial use shift.

A baseline can help authorities measure progress, but it must be followed by regular data collection and transparent reporting.

The survey is therefore one component of the wider response rather than a complete solution on its own. <Cite refs={["turn585937search1","turn585937search11"]}/>

Why Antibiotic Use in Livestock Matters

Pate’s comments on antibiotic use in livestock have placed agricultural practices at the centre of Nigeria’s latest public health discussion.

Antimicrobial medicines may be used in animal healthcare to treat bacterial infections and, where authorised and appropriate, for other specific purposes. However, unnecessary or poorly managed use can contribute to the development and spread of resistant microorganisms.

The minister said the livestock sector uses more antibiotics than the human health sector, arguing that more responsible use in animals could reduce the pressure driving resistance that affects people.

The statement highlights why tackling antimicrobial resistance requires coordination between human healthcare and animal production.

Livestock, farms, food products and the environment can all form part of pathways through which resistant microorganisms or resistance genes spread. The precise risks depend on the organisms involved, production practices, hygiene, waste management and other conditions.

Poor biosecurity and inadequate infection prevention can increase disease risks in animal production, potentially creating greater demand for medicines.

Improving animal health can therefore be an important part of reducing unnecessary antimicrobial use.

Farmers need access to veterinary advice, appropriate diagnostics, vaccination where available, sound husbandry practices and reliable information about the correct use of medicines.

The goal is not to deny animals necessary treatment. Responsible use means that medicines are used when justified, under appropriate professional guidance, and according to applicable rules and instructions.

The agriculture sector also has a direct interest in preserving the effectiveness of antimicrobials. Resistant infections can affect animal health, productivity, food security and the livelihoods of people who depend on farming.

Nigeria’s approach brings together officials responsible for health, livestock development, agriculture and the environment to address these interconnected risks. <Cite refs={["turn585937search0","turn585937search14","turn585937search16"]}/>

The One Health Approach

The government’s response is built around the One Health principle, which recognises that human health, animal health and environmental conditions are connected.

Under this approach, the responsibility for controlling antimicrobial resistance is shared across sectors.

Health authorities can strengthen diagnosis, prescribing practices, infection prevention and patient education. Veterinary and livestock authorities can promote responsible medicine use, vaccination, biosecurity and disease prevention on farms.

Agricultural extension services can help farmers understand good production practices, while environmental authorities can address the handling of waste and other pathways through which resistant organisms may spread.

Laboratories and research institutions provide the evidence needed to track infections and evaluate interventions.

Coordination matters because measures taken in one sector may have limited effect if risks remain unaddressed elsewhere.

For example, promoting responsible antibiotic use in hospitals will not fully address resistance if unnecessary use continues elsewhere and resistant organisms can move between people, animals and the environment.

Similarly, reducing medicine use without improving disease prevention may leave patients or animals vulnerable to infections that require treatment.

A coordinated response seeks to reduce avoidable infections while preserving access to effective medicines for people and animals who genuinely need them.

Nigeria’s December ministerial conference is intended to advance this shared approach and translate international commitments into practical action. <Cite refs={["turn585937search14","turn585937search15","turn585937search16"]}/>

Prevention Must Come Before Unnecessary Treatment

Pate has stressed that preventing infections is an important way to reduce the need for antimicrobial medicines.

Prevention measures include vaccination, hand hygiene, clean water and sanitation, appropriate food handling, infection prevention in healthcare facilities and better biosecurity in animal production.

These measures can reduce the number of infections that occur in the first place.

When fewer people and animals become infected, there may be less need to use antimicrobial medicines. This can help reduce avoidable exposure and the pressure that contributes to resistance.

In healthcare facilities, consistent hand hygiene, cleaning, sterilisation where required and appropriate infection-control procedures can help limit the spread of microorganisms.

In communities, access to safe water and sanitation can reduce exposure to certain infectious agents. Vaccination can prevent specific diseases and, in some circumstances, reduce secondary complications that might otherwise lead to antimicrobial treatment.

For livestock producers, better housing, sanitation, nutrition, vaccination and biosecurity can help reduce the risk of disease outbreaks.

Prevention does not eliminate the need for treatment. People and animals will continue to develop infections that require appropriate medical or veterinary attention.

The objective is to avoid unnecessary treatment while ensuring that those who need medicines receive the correct care.

This distinction is essential. Antimicrobial stewardship should not be understood as a blanket restriction on necessary treatment, but as a way to preserve medicine effectiveness through informed and responsible use. <Cite refs={["turn585937search0","turn585937search15","turn585937search16"]}/>

Why Nigerians Should Avoid Self-Medication

The minister also warned against using antibiotics unnecessarily, noting that not every cough or catarrh requires antibiotic treatment.

Many respiratory illnesses are caused by viruses, against which antibiotics do not work. Other symptoms can have different causes, and it is not possible to determine the appropriate treatment from symptoms alone in every case.

Taking antibiotics without proper assessment can expose a person to unnecessary side effects and contribute to the broader problem of resistance.

Using medicines incorrectly, taking someone else’s prescription or obtaining antibiotics without appropriate guidance can also delay the diagnosis of an underlying condition that needs different treatment.

Nigerians experiencing symptoms that concern them should seek advice from a qualified healthcare professional, particularly if symptoms are severe, persistent or worsening.

Patients who are prescribed antibiotics should follow the instructions provided by their clinician and ask a healthcare professional if they are uncertain about the dose, duration, side effects or what to do if they miss a dose.

People should not share prescribed medicines or reuse leftover antibiotics for a new illness without professional advice.

The correct treatment depends on the suspected or confirmed infection, the patient’s circumstances and relevant clinical guidance.

Responsible medicine use is only one part of the response, but it is an area where informed decisions by patients and healthcare professionals can make a difference.

The government’s warning reinforces the need for public education alongside stronger laboratory capacity and professional oversight. <Cite refs={["turn585937search0","turn585937search16"]}/>

The Role of Diagnostic Laboratories

Laboratory testing can help clinicians identify the microorganisms responsible for infections and determine which medicines are likely to be effective.

Without appropriate diagnostics, treatment may sometimes rely on symptoms, clinical experience and locally available information rather than a test identifying the organism and its susceptibility to medicines.

Clinical judgement remains important, especially when a patient needs urgent treatment. But reliable laboratory information can support more targeted decisions and help clinicians adjust treatment when results become available.

Nigeria faces challenges in expanding and coordinating this capacity.

A study cited in the latest reporting on antimicrobial resistance assessed 302 laboratories in Nigeria and found significant gaps in readiness for AMR surveillance. Only 7.3 per cent of the laboratories surveyed were classified as fully ready for surveillance, while 12.3 per cent reported participating in AMR surveillance.

The findings suggest that surveillance capacity was concentrated in certain government and tertiary laboratories, leaving other facilities and communities less represented.

These figures describe the laboratories included in that study; they should not be treated as a complete census of every laboratory operating in Nigeria today.

Nevertheless, the reported limitations illustrate the need to invest in laboratory infrastructure, trained personnel, standardised procedures and dependable reporting systems.

Expanding diagnostic capacity can help improve treatment decisions for individual patients while strengthening the evidence available to public health authorities.

It also requires a system for sharing and analysing results. Laboratory equipment alone cannot provide a national picture if findings are not reported consistently and used in clinical and policy decisions. <Cite refs={["turn585937search1","turn585937search11"]}/>

The December Conference in Abuja

Nigeria is scheduled to host the fifth Global High-Level Ministerial Conference on Antimicrobial Resistance from December 6 to 8, 2026.

The event will bring the issue to an international audience while giving participating governments and institutions an opportunity to discuss how commitments can be translated into action.

The announced theme is “One Health: Advancing Global AMR Commitments to Local Action.”

The conference is being prepared through cooperation among the Federal Ministry of Health and Social Welfare, the Ministry of Livestock Development, the Ministry of Agriculture and Food Security and the Ministry of Environment.

Organisers say the meeting is intended to strengthen accountability, support sustainable financing and encourage practical approaches to reducing antimicrobial resistance.

The programme is also expected to advance work towards an Abuja Compact on AMR, according to the official conference roadmap.

The conference comes after international commitments on antimicrobial resistance, including the 2024 United Nations political declaration. The challenge for participating governments is to turn such commitments into funded national plans, effective regulation and measurable improvements in prevention, diagnosis and treatment.

Hosting the meeting gives Nigeria an opportunity to highlight its own surveillance needs while participating in the wider global response.

However, the conference itself will not resolve the country’s challenges. Progress will depend on implementation after the meeting, including investment in laboratories, coordination between sectors, public education and sustained monitoring. <Cite refs={["turn585937search14","turn585937search15","turn585937search16"]}/>

What Needs to Happen Next

The government’s acknowledgement of surveillance gaps points to several priorities.

First, Nigeria needs more reliable and representative information on resistant infections. This includes strengthening laboratory capacity, improving reporting and ensuring that information from different levels of the healthcare system can be compared and analysed.

Second, health professionals need access to appropriate diagnostic tools and up-to-date guidance that supports responsible prescribing.

Third, prevention efforts must extend beyond hospitals. Vaccination, hygiene, safe food practices and effective infection control can reduce the number of infections that require treatment.

Fourth, animal-health and agricultural programmes need practical support to promote responsible antimicrobial use, including veterinary advice, farmer education, biosecurity and better disease prevention.

Fifth, public education must help people understand why antibiotics are not suitable for every illness and why medicines should not be used without appropriate guidance.

Finally, policy commitments need funding, clear responsibilities and measurable indicators. The impact of a national plan should be assessed through improvements in surveillance, appropriate medicine use, infection prevention and health outcomes.

These actions are connected. Better monitoring helps identify where interventions are needed, while prevention and responsible use help reduce the conditions that drive resistance.

A Public Health Challenge That Requires Shared Responsibility

Nigeria’s latest warning about antimicrobial resistance highlights a threat that can affect patients, hospitals, farmers, food systems and the wider economy.

The government’s acknowledgement of surveillance gaps is an important indication that better data are needed to understand the problem and guide the response. The planned national survey and the December ministerial conference provide opportunities to strengthen that effort, although their results will depend on implementation and follow-through.

Pate’s warning about antibiotic use in livestock also reinforces the need to treat drug resistance as a shared challenge involving human health, animal health and the environment.

For the public, the practical message is to avoid self-medication with antibiotics and seek appropriate professional advice. For healthcare providers, reliable diagnosis and responsible prescribing remain central. For farmers and veterinary professionals, disease prevention and careful use of medicines can help protect both animal health and the effectiveness of available treatments.

For government, the task is to strengthen the systems that connect these efforts: laboratories, surveillance, regulation, professional training and public education.

Antimicrobial resistance is not a problem that can be solved by one ministry or one group of professionals. It requires coordinated action and sustained investment.

As Nigeria prepares to host international health leaders in Abuja in December, the central test will be whether renewed attention produces stronger monitoring, better prevention and more responsible use of medicines in everyday practice.

Sources used for verification

1. Premium Times — AMR: Nigeria admits gaps in tracking drug-resistant infections, October 13, 2026: https://www.premiumtimesng.com/news/headlines/916591-amr-nigeria-admits-gaps-in-tracking-drug-resistant-infections.html

2. Premium Times — AMR: Livestock uses more antibiotics than human health sector – Pate, October 13, 2026: https://www.premiumtimesng.com/health/health-news/916593-amr-livestock-uses-more-antibiotics-than-human-health-sector-pate.html

3. Federal Ministry of Information and National Orientation — Nigeria to Host First Ever Global AMR Conference on Africa Soil, Harps on Prevention Through Multisectoral Approach, October 12, 2026: https://fmino.gov.ng/nigeria-to-host-first-ever-global-amr-conference-on-africa-soil-harps-on-prevention-through-multisectoral-approach/

4. Official 5th Global High-Level Ministerial Conference on AMR: https://5thghlamr.health.gov.ng/

5. Federal Ministry of Health and Social Welfare — Nigeria to Host 5th Global High-Level Ministerial Conference on Antimicrobial Resistance in 2026: https://health.gov.ng/press-release-nigeria-to-host-5th-global-high-level-ministerial-conference-on-antimicrobial-resistance-in-2026/